The medical world has taken a revolutionary step forward with the approval of ELEVIDYS, the first gene therapy for treating Duchenne Muscular Dystrophy (DMD). Developed by Sarepta Therapeutics, this innovative treatment targets the underlying cause of DMD, providing hope to countless patients affected by this devastating disorder. This article delves into the FDA approval of ELEVIDYS,...